STOCK TITAN

Heartflow (HTFL) CEO converts options into 31,220 common shares

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Heartflow, Inc. reported that Chief Executive Officer John C.M. Farquhar exercised stock options covering 31,220 shares of common stock on 2026-07-30. The options converted at exercise prices of $2.22, $8.33 and $9.58 per share. Footnotes describe vesting schedules with monthly installments continuing until July 1, 2027 and November 12, 2028 for certain grants, while another grant is already fully exercisable.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Farquhar John C.M.
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Stock Option F1 18,694 $0.00 $0.00
Exercise Stock Option F2 2,789 $0.00 $0.00
Exercise Stock Option F3 9,737 $0.00 $0.00
Exercise Common Stock 2,789 $8.33 $23K
Exercise Common Stock 18,694 $2.22 $42K
Exercise Common Stock 9,737 $9.58 $93K
Holdings After Transaction: Stock Option — 2,232,383 shares (Direct); Common Stock — 466,593 shares (Direct)
Footnotes (3)
  1. F1. The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
  2. F2. These stock options are fully exercisable.
  3. F3. The option vests and becomes exercisable in monthly installments until November 12, 2028, subject to continued service through the applicable vesting date.
Options exercised 31,220 shares Total underlying common shares from option exercises on 2026-07-30
Exercise price $2.2200 per share Stock option exercise into common stock on 2026-07-30
Exercise price $8.3300 per share Stock option exercise into common stock on 2026-07-30
Exercise price $9.5800 per share Stock option exercise into common stock on 2026-07-30
Option expiration 2033-07-10 Expiration date for stock option with $2.2200 exercise price
Option expiration 2031-08-24 Expiration date for stock option with $8.3300 exercise price
Option expiration 2034-12-26 Expiration date for stock option with $9.5800 exercise price
Stock Option financial
"Security title is reported as Stock Option for several derivative entries."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Exercise or conversion of derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
Common Stock financial
"Underlying security shares acquired are listed as Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Heartflow (HTFL) report for its CEO?

Heartflow reported that CEO John C.M. Farquhar exercised stock options into 31,220 common shares on 2026-07-30. The Form 4 shows option exercises and resulting share acquisitions, rather than open-market purchases or sales of Heartflow common stock.

How many Heartflow (HTFL) stock options did the CEO exercise and at what prices?

The CEO exercised options covering 31,220 shares of Heartflow common stock at $2.22, $8.33 and $9.58 per share. These exercises correspond to three separate stock option grants with different strike prices and expiration dates.

Were John C.M. Farquhar’s Heartflow (HTFL) options fully vested?

One stock option grant referenced in the Form 4 is described as fully exercisable. Other grants vest and become exercisable in monthly installments, with vesting schedules running until July 1, 2027 and November 12, 2028, subject to continued service.

Does this Heartflow (HTFL) Form 4 show any market sales of common stock?

No market sales are reported; the transactions are coded M for exercise or conversion of derivative securities. The filing shows option exercises resulting in common stock acquisitions, without any separate purchase (P) or sale (S) transactions listed.

What are the expiration dates of the Heartflow (HTFL) options exercised by the CEO?

The exercised stock options carry expiration dates of 2033-07-10, 2031-08-24 and 2034-12-26. These dates correspond to the three separate option grants that were partially or fully exercised into Heartflow common stock on 2026-07-30.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Farquhar John C.M.

(Last)(First)(Middle)
C/O HEARTFLOW, INC.
135 MAIN STREET, SUITE 1000

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/30/2026M2,789A$8.33438,162D
Common Stock07/30/2026M18,694A$2.22456,856D
Common Stock07/30/2026M9,737A$9.58466,593D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$2.2207/30/2026M18,694 (1)07/10/2033Common Stock18,694$01,984,637D
Stock Option$8.3307/30/2026M2,789 (2)08/24/2031Common Stock2,789$065,703D
Stock Option$9.5807/30/2026M9,737 (3)12/26/2034Common Stock9,737$0182,043D
Explanation of Responses:
1. The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
2. These stock options are fully exercisable.
3. The option vests and becomes exercisable in monthly installments until November 12, 2028, subject to continued service through the applicable vesting date.
/s/ Nga Van, by power of attorney07/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)